Mortgage refinance rates experienced a slight decline for the second day in a row, with 30-year refinance loans decreasing by another basis point on Tuesday, following a dip on Monday. This has brought the average rate down to 6.95%. In contrast, last Friday saw a quarter percentage point increase, marking the highest level since before […]
Mortgage Refinance Rates Drop for Second Consecutive Day Read More »
As of December 13, 2024, there are only two opportunities left to secure a Certificate of Deposit (CD) rate of 5% or higher. Nuvision Credit Union is leading the nation with a CD rate of 5.50% for an 8-month term, but it comes with a deposit limit of $5,000. For those looking to invest larger
Top CD Rates Today: Lock in 5% or More Before It’s Too Late Read More »
Key Takeaways: Brown-Forman, owner of Jack Daniel’s whiskey, was the S&P 500’s best-performing company on Thursday. The alcohol maker reported fiscal second-quarter revenue of $1.11 billion, down 1% year-over-year but above the analyst consensus from Visible Alpha. Net income was $242 million, or 50 cents per share, compared to $258 million or 55 cents per
Jack Daniel’s Parent Tops S&P 500: Stronger-Than-Expected Results Read More »
Nissan and Honda have publicly acknowledged the possibility of a merger, sparking significant interest in the automotive sector. According to a statement from Nissan and various media reports, the two companies have been in discussions regarding a potential merger for months, although no final decisions have been made. Nissan shares experienced a dramatic increase of
Nissan and Honda Consider Merger, Stock Prices React Read More »
Jefferies has initiated a ‘buy’ rating on Rocket Pharmaceuticals. The biotech firm’s experimental gene therapies are the basis for this rating. Jefferies also set a price target of $29. The analysts are optimistic about Rocket’s treatment for a rare genetic heart condition, which they believe could be a $1 billion opportunity for the company. Shares
Rocket Pharmaceuticals Stock Surges as Jefferies Initiates ‘Buy’ Coverage Read More »
